Origo Biopharma, S.L.

Innovative small molecules to treat the immune system

Origo is a biotech company developing a new generation of therapeutic products for the treatment of several diseases linked to TGF-β in gastrointestinal and lung indications. Founded by biotech/pharma executives from Palobiopharma and Galchimia.